ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress. 2009

Adrienne N Howard, and Kathleen A Bridges, and Raymond E Meyn, and Joya Chandra
Department of Pediatrics Research, The University of Texas M D Anderson Cancer Center, Box 853, 1515 Holcombe Blvd, Houston, TX 77030, USA.

OBJECTIVE This study assessed the role of oxidative stress and loss of glutathione in ABT-737-induced apoptosis. METHODS Jurkat human acute lymphocytic leukemia cells and HeLa cells transfected with a tet-regulated Bcl-2 expression system were treated with ABT-737 or its less active stereoisomer. GSH concentrations, intracellular reactive oxygen species (ROS), caspase activation and apoptotic DNA fragmentation were measured. RESULTS ABT-737 induced oxidative stress through decreased GSH and increased intracellular hydrogen peroxide and superoxide levels. Apoptotic DNA fragmentation and caspase activation were the consequences of this oxidative stress. Combining ABT-737 with ROS-inducing agents such as adaphostin or etoposide enhanced cell death. CONCLUSIONS These results demonstrate that inhibition of Bcl-2 causes a loss of GSH, an increase in ROS, caspase activation and subsequent apoptosis. Clinically, redox alterations as a consequence of Bcl-2 inhibition by ABT-737 should be considered in devising combination therapies with this novel agent or its derivatives.

UI MeSH Term Description Entries
D009596 Nitrophenols PHENOLS carrying nitro group substituents. Nitrophenol
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D001713 Biphenyl Compounds Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings. Compounds, Biphenyl
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide

Related Publications

Adrienne N Howard, and Kathleen A Bridges, and Raymond E Meyn, and Joya Chandra
January 2011, Cancer research,
Adrienne N Howard, and Kathleen A Bridges, and Raymond E Meyn, and Joya Chandra
July 2011, Transplant international : official journal of the European Society for Organ Transplantation,
Adrienne N Howard, and Kathleen A Bridges, and Raymond E Meyn, and Joya Chandra
May 2012, Blood,
Adrienne N Howard, and Kathleen A Bridges, and Raymond E Meyn, and Joya Chandra
August 2010, Journal of immunology (Baltimore, Md. : 1950),
Adrienne N Howard, and Kathleen A Bridges, and Raymond E Meyn, and Joya Chandra
August 2011, BMC cancer,
Adrienne N Howard, and Kathleen A Bridges, and Raymond E Meyn, and Joya Chandra
January 2014, Leukemia research reports,
Adrienne N Howard, and Kathleen A Bridges, and Raymond E Meyn, and Joya Chandra
January 2016, Cancer cell international,
Adrienne N Howard, and Kathleen A Bridges, and Raymond E Meyn, and Joya Chandra
February 2009, Blood,
Adrienne N Howard, and Kathleen A Bridges, and Raymond E Meyn, and Joya Chandra
April 2009, The Journal of investigative dermatology,
Adrienne N Howard, and Kathleen A Bridges, and Raymond E Meyn, and Joya Chandra
January 2013, Cell death and differentiation,
Copied contents to your clipboard!